Table 1 Correlation of PRCC expression and clinical features of HCC patients
Variables | Low (n = 33) | High (n = 33) | P-value |
|---|---|---|---|
Gender, n (%) | Â | Â | 0.741 |
 Female | 6 (18.2) | 5 (15.2) |  |
 Male | 27 (81.8) | 28 (84.8) |  |
Age, n (%) | Â | Â | 0.218 |
 ≤ 50 | 14 (42.4) | 19 (57.6) |  |
 > 50 | 19 (57.6) | 14 (42.4) |  |
HBV, n (%) | Â | Â | 0.689 |
 Negative | 4 (12.1) | 3 (9.1) |  |
 Positive | 29 (87.9) | 30 (90.9) |  |
Cirrhosis, n (%) | Â | Â | 0.689 |
 No | 4 (12.1) | 3 (9.1) |  |
 Yes | 29 (87.9) | 30 (90.9) |  |
AFP, n (%) | Â | Â | 0.032 |
 Negative, < 20 µg/L | 14 (42.4) | 6 (18.2) |  |
 Positive, ≥ 20 µg/L | 19 (57.6) | 27 (81.8) |  |
Tumor size, n (%) | Â | Â | 0.398 |
 ≤ 3 cm | 10 (30.3) | 7 (21.2) |  |
 > 3 cm | 23 (69.7) | 26 (78.8) |  |
Tumor number, n (%) | Â | Â | 0.492 |
 = 1 | 6 (18.2) | 4 (12.1) |  |
 > 1 | 27 (81.8) | 29 (87.9) |  |
PVTT, n (%) | Â | Â | 0.046 |
 No | 6 (18.2) | 1(3.0) |  |
 Yes | 27 (81.8) | 32 (97.0) |  |
TNM stage, n (%) | Â | Â | 0.030 |
 I and II | 10 (30.3) | 3 (9.1) |  |
 III and IV | 23 (69.7) | 30 (90.9) |  |